LTAGX | RERAX | LTAGX / RERAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 23 years | - |
Gain YTD | 10.226 | -0.768 | -1,331% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.91M | 126B | 0% |
Annual Yield % from dividends | 0.63 | 0.91 | 69% |
Returns for 1 year | 11.55 | 0.34 | 3,382% |
Returns for 3 years | -6.38 | -14.91 | 43% |
Returns for 5 years | N/A | -1.93 | - |
Returns for 10 years | N/A | 13.47 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HCPIX | 100.21 | 1.50 | +1.52% |
ProFunds UltraSector Health Care Inv | |||
TREPX | 13.25 | 0.12 | +0.91% |
Nuveen International Eq Premier | |||
NCVLX | 12.34 | 0.02 | +0.16% |
Nuance Concentrated Value Institutional | |||
MACPX | 25.99 | N/A | N/A |
BlackRock Sustainable Balanced Instl | |||
LOMGX | 32.44 | -0.15 | -0.46% |
Lord Abbett Growth Opportunities F3 |